There are 2773 resources available
192P - Neoadjuvant chemotherapy (NACT) for estrogen and HER2 normal breast cancer (TNBC) in Denmark
Presenter: William Thomassen
Session: ePoster Display
193P - Adjuvant endocrine therapy in patients with breast cancer: Relationship between side effects, quality of life and treatment adherence
Presenter: Alda Tavares
Session: ePoster Display
194P - Stromal tumor-infiltrating lymphocyte scores in core needle biopsy and its correlation to complete pathological response to neoadjuvant systemic therapy
Presenter: Klara Gersak
Session: ePoster Display
195P - A prognostic signature based on two-miRNA and pathological data in early-stage HER2+ breast cancer patients
Presenter: Anna Adam Artigues
Session: ePoster Display
196P - Targeting ESR1 in breast cancer treatment: Repurposing of statins
Presenter: Eva Rahman Kabir
Session: ePoster Display
197P - Application of neo-bioscore staging to predict the benefit of pertuzumab in HER2 positive early breast cancer
Presenter: Laura Sánchez Escudero
Session: ePoster Display
198P - Complications associated with prolonged GCSF with dose-dense EC chemotherapy for early breast cancer patients
Presenter: Taha Amir
Session: ePoster Display
200TiP - ELEANOR: A multi-national, prospective, non-interventional study (NIS) in patients with human epidermal growth factor receptor (HER2) positive, early breast cancer (eBC) observing real-life extended adjuvant treatment with neratinib and concurrent use of the eHealth solution CANKADO
Presenter: Nadia Harbeck
Session: ePoster Display
201TiP - Evaluation of the feasibility of ultrasound-guided clipping of suspicious intramammary lesions in primary breast cancer patients receiving neoadjuvant therapy (Ultra3Detect)
Presenter: Efstathia Vlachou
Session: ePoster Display